MergerLinks Header Logo

Announced

Completed

Altaris Capital Partners completed the acquisition of 3M's drug delivery business for c. $650m.

Synopsis

Altaris Capital Partners, an investment firm, completed the acquisition of a drug delivery business of 3M, an American multinational conglomerate, for c. $650m. Following the acquisition, Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, launched as an independent company. "We are excited to be partnering with 3M and the Kindeva team in this transaction. We believe Kindeva is well-positioned to build on its successful track record as a leading provider of drug delivery technologies," George Aitken-Davies, Altaris Managing Director.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US